|
1
|
Secondary GN
|
40
|
23.4
|
|
2
|
General CKD prevention – proteinuria, lipids, BP
|
37
|
21.6
|
|
3
|
Primary GN
|
35
|
20.4
|
|
4
|
Transplant Issues for the General Nephrologist
|
33
|
19.3
|
|
5
|
Fluids/Electrolytes/Acid-base
|
32
|
18.7
|
|
6
|
Geriatric Nephrology
|
31
|
18.0
|
|
7
|
Ethics in Nephrology
|
29
|
17.0
|
|
8
|
Pregnancy and Renal Disease
|
28
|
16.4
|
|
9
|
Tubulointerstitial Nephritis
|
21
|
12.3
|
|
10
|
Ischemic Nephropathy and Renovascular Hypertension
|
20
|
11.7
|
|
11
|
ARF/AKI – Staging and Therapy
|
19
|
11.1
|
|
12
|
Diabetic Nephropathy
|
18
|
10.5
|
|
13
|
Essential Hypertension
|
17
|
9.9
|
|
13
|
Genetic Diseases including PCKD
|
17
|
9.9
|
|
13
|
Radiographic Interventions and the Kidney
|
17
|
9.9
|
|
16
|
Thrombotic Microangiopathy
|
16
|
9.4
|
|
16
|
Nephrolithiasis
|
16
|
9.4
|
|
16
|
Management of Overdoses
|
16
|
9.4
|
|
19
|
General CKD Staging – Scr, Ccr, Cockcroft-Gault, eGFR
|
12
|
7.0
|
|
20
|
OTHER: CAKUT
|
4
|
2.3
|
|
20
|
OTHER: CKD Screening
|
4
|
2.3
|
|
20
|
OTHER: Renal Pathology
|
4
|
2.3
|
|
23
|
OTHER: Onconephrology
|
1
|
0.6
|
|
23
|
OTHER: CQI
|
1
|
0.6
|
